Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders

2003 ◽  
Vol 18 (S7) ◽  
pp. S22-S27 ◽  
Author(s):  
Vicky Marshall ◽  
Donald G. Grosset
2001 ◽  
Vol 28 (8) ◽  
pp. 923-928 ◽  
Author(s):  
Yen-Kung Chen ◽  
Ren-Shyan Liu ◽  
Wen-Sheng Huang ◽  
Shiaw-Pyng Wey ◽  
Gann Ting ◽  
...  

2003 ◽  
Vol 18 (S7) ◽  
pp. S34-S38 ◽  
Author(s):  
Durval C. Costa ◽  
Zuzana Walker ◽  
Rodney W.H. Walker ◽  
Fl�via R.G. Fontes

2021 ◽  
Vol 22 (20) ◽  
pp. 11234
Author(s):  
Giovanni Palermo ◽  
Sara Giannoni ◽  
Gabriele Bellini ◽  
Gabriele Siciliano ◽  
Roberto Ceravolo

A major goal of current clinical research in Parkinson’s disease (PD) is the validation and standardization of biomarkers enabling early diagnosis, predicting outcomes, understanding PD pathophysiology, and demonstrating target engagement in clinical trials. Molecular imaging with specific dopamine-related tracers offers a practical indirect imaging biomarker of PD, serving as a powerful tool to assess the status of presynaptic nigrostriatal terminals. In this review we provide an update on the dopamine transporter (DAT) imaging in PD and translate recent findings to potentially valuable clinical practice applications. The role of DAT imaging as diagnostic, preclinical and predictive biomarker is discussed, especially in view of recent evidence questioning the incontrovertible correlation between striatal DAT binding and nigral cell or axon counts.


Author(s):  
Dokyung Lee ◽  
Il Ki Hong ◽  
Tae-Beom Ahn

AbstractObjective: The radiological and clinical significance of a dilated Virchow-Robin space (dVRS) in the striatum (STR) remains unclear. We investigated the role of dVRS in STR on parkinsonism and dopamine transporter positron emission tomography (DaT-PET) findings. Methods: Patients with parkinsonism who underwent both brain magnetic resonance imaging and DaT-PET were included. Clinical status was evaluated by Hoehn and Yahr (HY) stage, Korean-Mini Mental Status Examination (K-MMSE), Montreal Cognitive Assessment Korea (MoCA-K), and Frontal Assessment Battery (FAB). dVRS was assessed by semi-quantitative and quantitative scales in each of the three segments of STR (caudate nuclei, anterior and posterior putamen) and was expressed as a dVRS score. DaT-PET was qualitatively assessed as either normal or abnormal in each segment. The relationship between dVRS and DaT-PET abnormality (ab-DaT-PET) was designated in each segment as either concordant or discordant. A concordant segment was defined by the presence of dVRS with ab-DaT-PET [Concordance rate (CR)=number of concordant segments/number of concordant and discordant segments]. Results: Eleven patients were included. There was no significant correlation between the presence of dVRS and ab-DaT-PET. The mean CR was 0.39. CR was not significantly correlated with any clinical or neuroimaging scales. The dVRS score was significantly correlated with K-MMSE, MoCA-K, and FAB (r=−0.675, −0.847, and −0.868, respectively) but not with HY stage. Conclusion: dVRS in STR played no significant role on dopaminergic innervation revealed by DaT-PET and made little contribution to clinical parkinsonism; however, it was correlated with cognitive impairment.


2017 ◽  
Vol 16 ◽  
pp. 586-594 ◽  
Author(s):  
Hongyoon Choi ◽  
Seunggyun Ha ◽  
Hyung Jun Im ◽  
Sun Ha Paek ◽  
Dong Soo Lee

Sign in / Sign up

Export Citation Format

Share Document